SNCA and Parkinson disease: Prior research has suggested that cognitive impairment in Parkinson’s disease is neurologically defined by the accumulation of ɑ-synuclein in the cortex, encompassing the limbic and neocortical regions of the brain.6,31 Given the significant correlations found between DTI-ALPS and cognitive function, we investigated whether this association was mediated by cortical integrity.